Marshall Wace North America L.P. - ARRAY BIOPHARMA INC ownership

Back to all holdings Add to watchlist

ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 324 filers reported holding ARRAY BIOPHARMA INC in Q2 2019. The put-call ratio across all filers is 1.86 and the average weighting 0.6%.

Links
Filings
External links
Quarter-by-quarter ownership
Marshall Wace North America L.P. ownership history of ARRAY BIOPHARMA INC
ValueSharesWeighting
Q1 2019$124,550,000
+66862.4%
5,108,762
+38957.8%
0.44%
+21950.0%
Q4 2018$186,000
-96.6%
13,080
-98.1%
0.00%
-95.0%
Q2 2017$5,417,000
-7.1%
677,109
+4.6%
0.04%
-13.0%
Q1 2017$5,828,000–647,566–0.05%–
 Download
Other shareholders

There were no reported owners of ARRAY BIOPHARMA INC in Q2 2019.

NameSharesValueWeighting ↓
View complete list of ARRAY BIOPHARMA INC shareholders